Navigation Links
Feinstein Institute to Receive $330,000 Grant to Support Research of Childhood Cancer
Date:9/19/2013

Manhasset, NY (PRWEB) September 19, 2013

The Feinstein Institute for Medical Research announced today it will receive $330,000 in grants aimed at gaining a better understanding of a pediatric cancer syndrome called Diamond Blackfan anemia. The grants were awarded by the St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research. It will support the work of a Feinstein Institute physician-researcher and consortium.

Sharon Singh, MD, will receive $230,000 to support her research project focused on Diamond Blackfan anemia. Diamond Blackfan anemia is an inherited condition that leads to anemia, possible birth defects and cancer. Dr. Singh’s team is working to understand the conditions that promote the formation and survival of cancer cells in this syndrome, to improve early diagnosis and treatment of childhood cancer.

“I am very thankful to receive this grant as it will support me in working to identify what conditions may lead to the development of cancer in children,” said Dr. Singh. “If my colleagues and I can identify why certain children develop cancer while others do not, we may be able to prevent future children from suffering from cancer.”

The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium at the Feinstein Institute, led by Johnson Liu, MD, will receive $100,000 to support ongoing work. The consortium is focused on a group of childhood disorders including Diamond-Blackfan anemia. Specifically, the researchers who comprise the consortium are exploring different ways they can manage Diamond-Blackfan anemia once a patient is diagnosed with it so that it doesn’t lead to anemia and cancer.

“The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium is a very unique group – I don’t know of another group in the world that has the concerted effort and capability to study Diamond Blackfan anemia or pre-leukemia in children,” said Dr. Liu. “The support by the St. Baldrick’s Foundation will enable us to continue and expand our research and hopefully identify new ways to manage or treat this deadly disease.”

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11131404.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
2. Summer Benefit Concert Raised More Than $1.5 Million for Feinstein Institute
3. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
4. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
5. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
6. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
7. Feinstein Institute Researcher provides insight into osteoarthritis
8. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
9. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
10. Feinstein Institute researchers discover plant derivative
11. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root NPI Graph today ... a new, greatly improved version of the Doctor Referral teaming dataset commonly available from ... and subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... ... in Erie, PA at the Sheraton Erie Bayfront and Erie Convention Center on ... based medicine experience, exhibits, a student quiz bowl, award and scholarship presentations, and ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or ... But how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional ... early symptoms of AMD? A study published recently in Dove Medical Press ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal ... prefer to read it, and some people don't like it at all. FindaTopDoc took ... they found: , Erotic literature can give readers a taste of their deepest, darkest ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... U.S. Food and Drug Administration (FDA) has notified the Company ... its Zhejiang, China manufacturing facility has ... successful clearance of the Warning Letter related to our ... measure of the progress we have made in our ongoing ...
(Date:6/9/2017)... and INDIANAPOLIS , June 9, ... living with diabetes. In a further effort to help ... affected by this condition, the International Diabetes Federation (IDF) ... ) have come together for the second phase of ... Systems programme (BRIDGES 2), reaffirming their commitment to helping ...
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
Breaking Medicine Technology: